miR‑140‑5p regulates angiogenesis following ischemic stroke by targeting VEGFA

Sun,Jijun; Tao,Shuxin; Liu,Lifeng; Guo,Dong; Xia,Zhangyong; Huang,Min

doi:10.3892/mmr.2016.5066

miR‑140‑5p regulates angiogenesis following ischemic stroke by targeting VEGFA

Authors:
- Jijun Sun
- Shuxin Tao
- Lifeng Liu
- Dong Guo
- Zhangyong Xia
- Min Huang
View Affiliations

Affiliations: Department of Neurology, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong 252000, P.R. China, Department of Neurology, Jinan University, Guangzhou, Guangdong 510632, P.R. China
Published online on: March 30, 2016 https://doi.org/10.3892/mmr.2016.5066
Pages: 4499-4505

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNA (miRNA or miR) expression profiles are altered in tissues under hypoxic-ischemic conditions. The expression of miR‑140 is downregulated >2-fold following hypoxic-ischemic brain damage, however, its role in angiogenesis subsequent to cerebral ischemia is not fully understood. The present study aimed to investigate the role of miR-140-5p in angiogenesis and the molecular mechanism mediated by vascular endothelial growth factor A (VEGFA) in an in vitro model for brain ischemia. A rat middle cerebral artery occlusion (MCAO) model was constructed, and the results from reverse transcription-quantitative polymerase chain reaction and western blot analysis demonstrated that the expression levels of miR-140‑5p were significantly decreased, while the expression levels of VEGFA were significantly increased between 12 and 48 h in the rat cerebral following MCAO. Furthermore, human umbilical vein endothelial cells (HUVECs) were exposed to low oxygen conditions and it was demonstrated that hypoxia downregulated miR-140-5p and upregulated VEGFA expression levels. The miR-140-5p mimic was transfected into the normoxic and hypoxic HUVECs and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Transwell migration and tube formation assays were performed. The results indicated that miR‑140‑5p inhibited angiogenesis by decreasing cell proliferation, migration and tube formation. Additionally, in human embryonic kidney 293 cells, results from the luciferase reporter assay revealed that miR‑140‑5p directly targeted the 3' untranslated region of VEGFA and that miR‑140‑5p regulated the protein expression of VEGFA. To further analyze this effect, a VEGFA‑pEGFP‑C1 plasmid was transfected into the normoxic and hypoxic HUVECs, and it was revealed that the inhibitory effect of miR‑140‑5p on angiogenesis was attenuated by the overexpression of VEGFA. In conclusion, to the best of our knowledge, the present study is the first to suggest that miR‑140‑5p exerts an inhibitory effect on angiogenesis in an in vitro model of ischemia, and this effect is achieved partially by targeting VEGFA. The present study provided a novel biomarker for the treatment of cerebral ischemia.

View Figures

View References

1	Wang X: Investigational anti-inflammatory agents for the treatment of ischaemic brain injury. Expert Opin Investig Drugs. 14:393–409. 2005. View Article : Google Scholar : PubMed/NCBI
2	Durukan A and Tatlisumak T: Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 87:179–197. 2007. View Article : Google Scholar : PubMed/NCBI
3	Arenillas JF, Sobrino T, Castillo J and Dávalos A: The role of angiogenesis in damage and recovery from ischemic stroke. Curr Treat Options Cardiovasc Med. 9:205–212. 2007. View Article : Google Scholar : PubMed/NCBI
4	Navarro-Sobrino M, Rosell A, Hernández-Guillamon M, Penalba A, Boada C, Domingues-Montanari S, Ribó M, Alvarez-Sabín J and Montaner J: A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. Atherosclerosis. 216:205–211. 2011. View Article : Google Scholar : PubMed/NCBI
5	Koutsis G, Siasos G and Spengos K: The emerging role of microRNA in stroke. Curr Top Med Chem. 13:1573–1588. 2013. View Article : Google Scholar : PubMed/NCBI
6	Peng T, Jia YJ, Wen QQ, Guan WJ, Zhao EY and Zhang BA: Expression of microRNA in neonatal rats with hypoxic-ischemic brain damage. Chin J Contemp Pediatr. 12:373–376. 2012.In Chinese.
7	Hatse S, Brouwers B, Dalmasso B, Laenen A, Kenis C, Schöffski P and Wildiers H: Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status. PLoS One. 9:e1106442014. View Article : Google Scholar : PubMed/NCBI
8	Mosakhani N, Lahti L, Borze I, Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P, Knuutila S and Sarhadi VK: MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF. Cancer Genet. 205:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
9	Yang H, Fang F, Chang R and Yang L: MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013. View Article : Google Scholar : PubMed/NCBI
10	Li W and He F: Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer. Biochem Biophys Res Commun. 450:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
11	Kai Y, Peng W, Ling W, Jiebing h and Zhuan B: Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. Biochem Biophys Res Commun. 448:308–314. 2014. View Article : Google Scholar : PubMed/NCBI
12	National Research Council: Guide for the Care and Use of Laboratory Animals. 8th edition. National Academies Press; 2011
13	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
16	Wen KC, Sung PL, Yen MS, Chuang CM, Liou WS and Wang PH: MicroRNAs regulate several functions of normal tissues and malignancies. Taiwan J Obstet Gynecol. 52:465–469. 2013. View Article : Google Scholar
17	Chan SH and Wang LH: Regulation of cancer metastasis by microRNAs. J Biomed Sci. 22:92015. View Article : Google Scholar : PubMed/NCBI
18	Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
19	Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF and Campochiaro PA: MicroRNAs regulate ocular neovascularization. Mol Ther. 16:1208–1216. 2008. View Article : Google Scholar : PubMed/NCBI
20	Dharap A, Bowen K, Place R, Li LC and Vemuganti R: Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab. 29:675–687. 2009. View Article : Google Scholar : PubMed/NCBI
21	Xu CF, Yu CH and Li YM: Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice. OMICS. 13:513–520. 2009. View Article : Google Scholar : PubMed/NCBI
22	Park CS and Tang SJ: Regulation of microRNA expression by induction of bidirectional synaptic plasticity. J Mol Neurosci. 38:50–56. 2009. View Article : Google Scholar
23	Viader A, Chang LW, Fahrner T, Nagarajan R and Milbrandt J: MicroRNAs modulate Schwann cell response to nerve injury by reinforcing transcriptional silencing of dedifferentiation-related genes. J Neurosci. 31:17358–17369. 2011. View Article : Google Scholar : PubMed/NCBI
24	Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P and Parsons MW: The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain. 132:2231–2238. 2009. View Article : Google Scholar : PubMed/NCBI
25	Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Turan TN, Cloft HJ and Chimowitz MI; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators: Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 69:963–974. 2011. View Article : Google Scholar : PubMed/NCBI
26	Rusanen H, Saarinen JT and Sillanpää N: Collateral Circulation Predicts the Size of the Infarct Core and the Proportion of Salvageable Penumbra in Hyperacute Ischemic Stroke Patients Treated with Intravenous Thrombolysis. Cerebrovasc Dis. 40:182–190. 2015. View Article : Google Scholar : PubMed/NCBI
27	Ernst M, Forkert ND, Brehmer L, Thomalla G, Siemonsen S, Fiehler J and Kemmling A: Prediction of infarction and reperfusion in stroke by flow- and volume-weighted collateral signal in MR angiography. AJNR Am J Neuroradiol. 36:275–282. 2015. View Article : Google Scholar
28	Folkman J and Shing Y: Angiogenesis. J Biol Chem. 267:10931–10934. 1992.PubMed/NCBI
29	Henry TD: Therapeutic angiogenesis. BMJ. 318:1536–1539. 1999. View Article : Google Scholar : PubMed/NCBI
30	Beck H and Plate KH: Angiogenesis after cerebral ischemia. Acta Neuropathol. 117:481–496. 2009. View Article : Google Scholar : PubMed/NCBI
31	Matsui M and Tabata Y: Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater. 8:1792–1801. 2012. View Article : Google Scholar : PubMed/NCBI
32	Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D, Murohara T, Principe N, Isner JM and Losordo DW: Divergence of angiogenic and vascular permeability signaling by VEGF: Inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol. 22:901–906. 2002. View Article : Google Scholar : PubMed/NCBI
33	Plate KH, Beck H, Danner S, Allegrini PR and Wiessner C: Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol. 58:654–666. 1999. View Article : Google Scholar : PubMed/NCBI
34	Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE and Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:2183–2189. 1994. View Article : Google Scholar : PubMed/NCBI
35	Lennmyr F, Ata KA, Funa K, Olsson Y and Terént A: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol. 57:874–882. 1998. View Article : Google Scholar : PubMed/NCBI
36	Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E and Risau W: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 156:965–976. 2000. View Article : Google Scholar : PubMed/NCBI
37	Hayashi T, Abe K, Suzuki H and Itoyama Y: Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke. 28:2039–2044. 1997. View Article : Google Scholar : PubMed/NCBI
38	Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N and Chopp M: VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 106:829–838. 2000. View Article : Google Scholar : PubMed/NCBI